Purchase Order HT001423P0313
- Not listed
- This delivery order, awarded to AmerisourceBergen Drug Corp on October 18, 2025, represents a $12,505.44 firm fixed-price contract with an ultimate completion date of October 20, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cibinqo 100 mg tablets in quantities of 30 units, with a ceiling value of $5,114.08. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025....
- The U.S. Defense Department's Medical Supply Chain awarded a $2,141.54 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued as a competitive award without set-aside provisions, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with the Defense Logistics Agency. The awardee, headquartered in Conshohocken, Pennsylvania, will perform work...
- AmerisourceBergen Drug Corp was awarded a Delivery Order valued at $2.03M by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of July 31, 2025. This Firm Fixed Price contract, awarded on July 30, 2025, represents a non-competitive set-aside delivery order under a larger indefinite delivery contract vehicle. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and serve as a critical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, with a ceiling value of $1,262.15. This firm fixed price delivery order, which is a child contract under a larger indefinite delivery vehicle, carries an ultimate completion date of October 16, 2025. The award was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical supply...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, with a ceiling value of $6,044.60 and an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a task order under AmerisourceBergen's broader relationship with the federal government's military healthcare procurement system. The prime contractor is headquartered in...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $20,002.02 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Blincyto 35 micrograms vials with stabilizers. This firm fixed-price, non-set-aside contract is scheduled for completion by October 16, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, valued at $2,252.58 with a completion date of September 15, 2025. This is a firm fixed price delivery order issued under a child contract with no set-aside designation, competitively awarded to the prime contractor headquartered in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical or medical supply transaction consistent with...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of October 21, 2025, and a ceiling value of $12,414.04. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with a ceiling value of $12,730.32. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for ultimate completion on October 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was...
Bluebin Inc. has been awarded a firm fixed-price purchase order by the Defense Health Agency (DHA) for Supply Chain Optimization Support Services, with a ceiling value of $4.52M. The contract, awarded on September 29, 2023, is scheduled for completion by September 29, 2026, and will be performed at Fort Belvoir, Virginia. No small business set-aside was utilized for this procurement. The Defense Health Agency, a component of the Department of Defense, selected Bluebin Inc. to support optimization initiatives within the military health system's supply chain operations. This engagement reflects DHA's ongoing efforts to enhance efficiency and effectiveness across its healthcare logistics and supply chain networks that support military beneficiaries and medical facilities worldwide. The three-year contract duration and substantial funding level indicate a significant strategic initiative to modernize supply chain processes and capabilities within the military health enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $1.4m | 9/29/25 | |
| P00003 | Funding Only Action | ($449k) | 4/17/25 | |
| P00002 | Supplemental Agreement for work within scope | $250.0k | 11/14/24 | |
| P00001 | Exercise an Option | $1.1m | 9/19/24 | |
| Not listed | Not listed | $2.2m | 9/29/23 |